AR and benign prostatic hyperplasia: In a study of twenty patients, Mohler et al., showed lower intensity immunostaining of AR in cancer stroma compared to regions of benign prostatic hyperplasia [7], but there was no correlation with cancer progression, possibly due to the small cohort size.